Fimepinostat, also known as CUDC-907, is a dual PI3K and HDAC inhibitor. Fimepinostat is able to enhance antitumor activity when combined with standard of care agents to inhibits cell growth in a wide variety of malignances. Reagent-grade; for laboratory research purposes only.
Products > Antibody Drug Conjugates (ADC), Oncology API > Oncology API
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye